JP2017514804A5 - - Google Patents

Download PDF

Info

Publication number
JP2017514804A5
JP2017514804A5 JP2016562579A JP2016562579A JP2017514804A5 JP 2017514804 A5 JP2017514804 A5 JP 2017514804A5 JP 2016562579 A JP2016562579 A JP 2016562579A JP 2016562579 A JP2016562579 A JP 2016562579A JP 2017514804 A5 JP2017514804 A5 JP 2017514804A5
Authority
JP
Japan
Prior art keywords
methyl
pyrimidine
pyridyl
diamine
cyclopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016562579A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017514804A (ja
JP6529983B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/056496 external-priority patent/WO2015165660A1/en
Publication of JP2017514804A publication Critical patent/JP2017514804A/ja
Publication of JP2017514804A5 publication Critical patent/JP2017514804A5/ja
Application granted granted Critical
Publication of JP6529983B2 publication Critical patent/JP6529983B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016562579A 2014-04-28 2015-03-26 マラリアの予防又は治療に有用なトリアミノピリミジン化合物 Active JP6529983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2142CH2014 2014-04-28
IN2142/CHE/2014 2014-04-28
PCT/EP2015/056496 WO2015165660A1 (en) 2014-04-28 2015-03-26 Triaminopyrimidine compounds useful for preventing or treating malaria

Publications (3)

Publication Number Publication Date
JP2017514804A JP2017514804A (ja) 2017-06-08
JP2017514804A5 true JP2017514804A5 (https=) 2018-05-17
JP6529983B2 JP6529983B2 (ja) 2019-06-12

Family

ID=52779638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016562579A Active JP6529983B2 (ja) 2014-04-28 2015-03-26 マラリアの予防又は治療に有用なトリアミノピリミジン化合物

Country Status (22)

Country Link
US (1) US9957253B2 (https=)
EP (1) EP3137455B1 (https=)
JP (1) JP6529983B2 (https=)
CN (1) CN106255685B (https=)
AP (1) AP2016009570A0 (https=)
BR (1) BR112016024467B1 (https=)
CA (1) CA2946654C (https=)
CY (1) CY1120700T1 (https=)
DK (1) DK3137455T3 (https=)
ES (1) ES2696350T3 (https=)
HR (1) HRP20181816T1 (https=)
HU (1) HUE042043T2 (https=)
LT (1) LT3137455T (https=)
MX (1) MX374458B (https=)
MY (1) MY178971A (https=)
PH (1) PH12016502322B1 (https=)
PL (1) PL3137455T3 (https=)
PT (1) PT3137455T (https=)
RS (1) RS58124B1 (https=)
SI (1) SI3137455T1 (https=)
SM (1) SMT201800588T1 (https=)
WO (1) WO2015165660A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105699584B (zh) * 2016-02-03 2018-02-09 昆药集团股份有限公司 一种蒿甲醚相关物质的检测方法
WO2018079629A1 (ja) 2016-10-26 2018-05-03 カルナバイオサイエンス株式会社 抗マラリア活性を有する新規ピリミジン誘導体
CN106727584A (zh) * 2017-02-08 2017-05-31 于贵庆 一种治疗骨病的药物组合物
JP2020532513A (ja) * 2017-09-05 2020-11-12 カディラ ヘルスケア リミティド トリアミノピリミジン化合物およびその中間体の調製方法
CN117327007B (zh) * 2023-09-26 2024-09-13 上海陶术生物科技有限公司 一种vt107的制备方法
WO2025115034A1 (en) * 2023-11-30 2025-06-05 Zydus Lifesciences Limited A process for the preparation of a triaminopyrimidine compound and novel intermediates thereof
EP4574143A1 (en) 2023-12-21 2025-06-25 Universität Regensburg Inhibitors of plasmodia remodeling enzymes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003286711A1 (en) * 2002-10-25 2004-05-13 Vertex Pharmaceuticals Incorporated Indazolinone compositions useful as kinase inhibitors
RU2405778C2 (ru) * 2004-09-30 2010-12-10 Тиботек Фармасьютикалз Лтд. 5-гетероциклилпиримидины, ингибирующие вич
WO2014058685A1 (en) * 2012-10-08 2014-04-17 Merck Sharp & Dohme Corp. Inhibitors of irak4 activity

Similar Documents

Publication Publication Date Title
JP2017514804A5 (https=)
US20110028510A1 (en) Compositions, Methods, and Kits for Treating Influenza Viral Infections
MX2010001677A (es) Derivados de 4-(9-(3,3-difluorociclopentil)-5,7,7-trimetil-6-oxo-6 ,7,8,9-tetrahidro-5h-pirimido[4,5-b][1,4]diazepin-2-ilamino)-3-me toxibenzamida como inhibidores de las proteinas cinasas humanas plk1 a plk4 para el tratamiento de enfermedades proli
AR119208A1 (es) DERIVADOS DE PIRROLO[1,2-c]IMIDAZOL COMO INHIBIDORES DE EGFR
JP2014505735A5 (https=)
US20170121321A1 (en) Proteolysis Targeting Chimera Compounds and Methods of Preparing and Using Same
JP2019505541A5 (https=)
JP2004527560A5 (https=)
RU2015148189A (ru) ПРОИЗВОДНЫЕ 2-АМИДОПИРИДО[4, 3-d]ПИРИМИДИН-5-ОНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ WEE-1
JP2014511893A5 (https=)
JP2016515098A5 (https=)
JP2013528204A5 (https=)
JP2017524702A5 (https=)
JP2015517976A5 (https=)
RU2012148133A (ru) Комбинация, включающая ингибитор циклинзависимой киназы 4 или циклинзависимой киназы 6 (cdk4/6) и ингибитор mtor, для лечения рака
JP2015514056A5 (https=)
JP2016537384A5 (https=)
SI2989100T1 (en) NAFTIRIDINE DERIVATIVES USED AS ANTAGONISTS INTEGRITY OF ALFA-V-BETA-6
JP2019504901A5 (https=)
JP2013512903A5 (https=)
AR107751A1 (es) Composiciones de forma de dosificación que comprenden un inhibidor de tirosina cinasa de bruton
JP2018529731A5 (https=)
IL281802B1 (en) Use of an inhibitor of an ent family transporter in the treatment of cancer and combination thereof with an adenosine receptor antagonist
HRP20100573T1 (hr) Triazolopiridinkarboksamidni derivati, njihovo dobivanje i njihova upotreba u terapiji
JP2017536409A5 (https=)